- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Carl replaces Wilson at Health Images
Imaging services provider Health Images has announced that chairmanand CEO Robert Carl has assumed the responsibilities of W.A. Wilsonas president of the Atlanta company. HI said Wilson resigned aspresident and chief administrative officer to pursue
Imaging services provider Health Images has announced that chairmanand CEO Robert Carl has assumed the responsibilities of W.A. Wilsonas president of the Atlanta company. HI said Wilson resigned aspresident and chief administrative officer to pursue other interests.
HI's announcement came shortly before the company releasedsecond-quarter results that show revenues of $32.4 million, comparedto $19.9 million in the second quarter of 1994. Much of the increasecame from HI's acquisition of 15 MedAlliance imaging centers.Net income from continuing operations for the quarter was $1.7million, compared to $1.6 million in the same period a year ago.
In other HI news, the company said it has received 510(k) clearancefor its inversion recovery with intense silicone (IRIS) pulsesequence. IRIS improves the ability of MRI to locate siliconewithin the body, improving the modality's utility in detectingruptures in silicone breast implants. IRIS is now available at33 Health Images centers.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
